2025 Drug Shortage Guardian Award Honors Federal Heroes Who Saved Lives During IV Fluid Crisis
Agencies recognized by patient advocacy organization, Angels for Change, for swift action and lifesaving logistics following hurricanes Helene and Milton.
Angels for Change (A4C) announces the pilot launch of Project GOLD (Generic Oncology Lifesaving Drugs), a new resiliency program that establishes an onshore buffer supply of six essential medications that are used to treat cancer. Project GOLD was created to offer physicians and patients stability of care during a shortage through emergency supply at leading distributors and manufacturers. A4C is participating with founding pilot members, pharmaceutical wholesalers Cencora and McKesson, and pharmaceutical and medtech manufacturer Fresenius Kabi.
Angels for Change (A4C) announces its 2024 Change Maker of the Year Award , Lindsey Thomas, Senior Vice President of Marketing at Fresenius Kabi USA. Lindsey was recognized for her exceptional leadership, collaborative spirit, and unwavering commitment to patient care, particularly in addressing the critical chemotherapy drug shortages during 2023 and 2024.
Bad Medicine: Why India Is Racing To Improve Pharma Standards Amid US-China Trade Rivalry | Insight
As drug shortages continue to threaten lives, a new geopolitical shift could shape where our medicines come from—and how safe they are. Thank you CNA Insider for investigating this crucial topic. A resilient drug supply chain is not just about availability, it’s about quality, transparency, and accountability.
Angels for Change was recently featured in a powerful News10 story highlighting our mission to end drug shortages and the critical impact our work has on patients across the country. The piece shares the story of Brooke, a patient in Warrensburg, N.Y., who faced a terrifying delay in receiving her IV fluid treatments due to a national shortage.
When traditional supply chain solutions failed, Brooke and her mother, Cathy, turned to Angels for Change. Through our national network and rapid advocacy efforts, we were able to help locate the essential IV fluids she needed to continue her care, demonstrating once again how patient-centered advocacy can make a life-saving difference.
Behind every shortage is a real person with real needs. Thank you, News10, for raising awareness around the drug shortage crisis. We are committed to advocating for patients, raising awareness, and building a more resilient and equitable pharmaceutical supply chain.
Watch the news segment below and read the news article here.
Angels for Change (A4C) announces the pilot launch of Project GOLD (Generic Oncology Lifesaving Drugs), a new resiliency program that establishes an onshore buffer supply of six essential medications that are used to treat cancer. Project GOLD was created to offer physicians and patients stability of care during a shortage through emergency supply at leading distributors and manufacturers. A4C is participating with founding pilot members, pharmaceutical wholesalers Cencora and McKesson, and pharmaceutical and medtech manufacturer Fresenius Kabi.
How Pharmaceutical Supply Chain Advancements are Meeting the Moment and Beyond panel at Milken Institute Future of Health Summit, moderated by Sarah Karlin-Smith from Citeline, with Panelists Laura Bray from Angels for Change, Shamiram Feinglass MD, MPH from Manatt, Phelps & Phillips, LLP, Kirk Kaminsky from McKesson and Vimala Raghavendran from US Pharmacopeia.
Thank you Fierce Healthcare for highlighting our work on the new White House Cancer Moonshot pilot to mitigate pediatric cancer drug shortages. The End Drug Shortages Alliance will coordinate participating healthcare providers, including Children’s Hospital of Philadelphia, Children’s National Hospital, Children’s Mercy Kansas City, Cincinnati Children’s Hospital Medical Center, Stanford Medicine Children’s Health, St. Jude Children’s Research Hospital, and Texas Children’s Hospital; pharmaceutical wholesalers, Cencora and Morris & Dickson; and advising partners Angels for Change, Children’s Hospital Association, and US Pharmacopeia. The pilot will launch before the end of the year and run into 2025.
Becker’s Healthcare spotlights the new White House Cancer Moonshot pilot aimed at mitigating pediatric cancer drug shortages.
“Healthcare providers participating in the pilot program are Children's Hospital of Philadelphia, Washington, D.C. - based Children's National Hospital, Children's Mercy Kansas City (Mo.), Cincinnati Children's Hospital Medical Center, Stanford (Calif.) Medicine Children's Health, Memphis, Tenn.-based St. Jude Children's Research Hospital and Houston-based Texas Children's Hospital. Pharmaceutical companies Cencora and Morris & Dickson, and nonprofit organizations Angels for Change, the Children's Hospital Association and US Pharmacopeia will also participate.” wrote Elizabeth Gregerson
[October 28th, 2024] Today, the White House announced a new pilot program under Biden Cancer Moonshot. Angels for Change is honored to be the trusted patient voice on this group-breaking initiative. We would like to thank all pilot members and the End Drug Shortages Alliance for joining this collaborative patient-focused work.
“This pilot program builds on the work the Biden Cancer Moonshot has led to ensure that children and families facing cancer have equitable resources and access to diagnosis, treatment, research, and survivorship care” - Office of Science and Technology Policy (Oct. 28, 2024). Biden Cancer Moonshot Announces New Pilot to Mitigate Pediatric Cancer Drug Shortages
